Overview

Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

Status:
Completed

Trial end date:
2017-07-24

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the efficacy and safety of subcutaneous administration of a liquid formulation of C1 esterase inhibitor for the prevention of angioedema attacks in adolescent and adult subjects with hereditary angioedema.

Phase:

Phase 3

Details

Lead Sponsor:

Shire

Treatments:

Complement C1 Inactivator Proteins
Complement C1 Inhibitor Protein
Complement C1s